$3,850.00 – $5,850.00
Published on: January 27, 2023The Global Epigenetics Market is calculated to reach USD 2.79 billion by 2024, growing at a CAGR of 15.12% during the forecast period 2019-2024. The increasing prevalence of cancer and other chronic diseases along with rising geriatric population is poised to bolster the growth of the market. Moreover, the increasing research activities and funding for research are also analyzed to propel the growth of market.
1 Global Epigenetics Market
1.1 Study Objectives
1.2 Market Definition
1.3 Study Scope
1.3.1 Markets Covered
1.3.2 Geographic Scope
2 RESEARCH METHODOLOGY
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.1.2.3 Breakdown of Primaries
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions
3 Global Epigenetics Market – Executive Summary
3.1 Market Revenue, Market Size and Key Trends by Company
3.2 Key Trends by type of Application
3.3 Key Trends segmented by Geography
4 Global Epigenetics Market – Comparative Analysis
4.1 Product Benchmarking – Top 10 companies
4.2 Top 5 Financials Analysis
4.3 Market Value split by Top 10 companies
4.4 Patent Analysis – Top 10 companies
4.5 Pricing Analysis
5 Global Epigenetics Market – Industry Market Entry Scenario
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis – Top 10 companies
6 Global Epigenetics Market – Market Forces
6.1 Introduction
6.2 Market Dynamics
6.2.1 Drivers
6.2.2 Opportunities
6.2.3 Challenges
6.3 Porters Analysis of Market
6.3.1 Bargaining power of suppliers
6.3.2 Bargaining powers of customers
6.3.3 Threat of new entrants
6.3.4 Rivalry among existing players
6.3.5 Threat of substitutes
7 Global Epigenetics Market – Strategic Analysis
7.1 Value Chain analysis
7.2 Product Life Cycle
7.3 Supplier and distributor analysis (Market share and product dealing strategies)
8 Global Epigenetics Market – By Product (Market Size – & million/billion)
8.1 Kits
8.2 Reagents
8.3 Enzymes
8.4 Bioinformatics Tools
8.5 Instruments and Consumables
9 Global Epigenetics Market – By Application
9.1 Oncology
9.2 Metabolic Diseases
9.3 Developmental Biology
9.4 Immunology
9.5 Cardiovascular Diseases
9.6 Other
10 Global Epigenetics Market – By Technology
10.1 DNA Methylation
10.2 Histone Modification
10.3 Other
11 Global Epigenetics Market – By End-User
11.1 Academic and Research Institutes
11.2 Pharmaceutical and Biotechnology Companies
11.3 Contract Research Organizations
12 Global Epigenetics Market – By Geography (Market Size – & million/billion)
12.1 Introduction
12.2 North America
12.2.1 US
12.2.2 Canada
12.2.3 Mexico
12.3 Europe
12.3.1 U.K
12.3.2 Germany
12.3.3 Italy
12.3.4 France
12.3.5 Spain
12.3.6 Rest of Europe
12.4 Asia-Pacific
12.4.1 China
12.4.2 Japan
12.4.3 India
12.4.4 South Korea
12.4.5 Rest of APAC
12.5 Rest of the World
12.5.1 South America
12.5.2 Middle East
12.5.3 Africa
13 Global Epigenetics Market – Entropy
13.1 New product launches
13.2 M&A’s, collaborations, JVs and partnerships
14 Global Epigenetics Market Company Profile (Key Players)
14.1 Market Share, Company Revenue, Products, M&A, Developments
14.2 Thermo Fisher Scientific
14.3 Illumina
14.4 New England Biolabs
14.5 Merck Millipore
14.6 Agilent
14.7 Qiagen
14.8 Active Motif
14.9 Bio-Rad
14.10 Zymo Research
14.11 Perkinelmer
14.12 Company 11 & more
15 Global Epigenetics Market – Appendix
15.1 Sources
15.2 Abbreviations
